Interlaboratory Analysis of Isavuconazole Plasma Concentration Assays Among European Laboratories
Federico Pea1, Robert Krause2, Carsten Müller3
1Department of Medicine, University of Udine, and Institute of Clinical Pharmacology, Santa Maria della Misericordia University Hospital, ASUIUD, Udine, Italy.
Background:
Under certain circumstances, clinicians treating patients with isavuconazole for invasive aspergillosis or mucormycosis may use therapeutic drug monitoring. However, the accuracy and reproducibility of the various assays used by different laboratories for the quantification of isavuconazole plasma concentrations have yet to be determined.
Methods:
Human plasma samples spiked with known concentrations of isavuconazole were provided to 27 European laboratories that took part in a "round-robin" test (an interlaboratory test performed independently at least 2 times; 2 rounds performed in the current study). Assay methods included liquid chromatography-tandem mass spectrometry (LC-MS/MS), LC with ultraviolet detection (LC-UV), LC with fluorescence detection (LC-FL), and bioassay. The accuracy and reproducibility compared with the known concentrations for each sample in each round were compared overall, between assays, and between laboratories.
Results:
Twenty-seven laboratories participated in the study (LC-MS/MS, n = 15; LC-UV; n = 9; LC-FL, n = 1; bioassay, n = 2). In round 1, for nominal concentrations of 1000, 1700, 2500, and 4000 ng/mL, the mean (SD) determined concentrations were 1007 (183), 1710 (323), 2528 (540), and 3898 (842) ng/mL, respectively. In round 2, for nominal concentrations of 1200, 1800, 2400, and 4000 ng/mL, the mean (SD) determined concentrations were 1411 (303), 2111 (409), 2789 (511), and 4723 (798) ng/mL, respectively. Over both rounds, determined concentrations were consistently within 15% of the nominal concentrations for 10 laboratories (LC-MS/MS, n = 4; LC-UV, n = 5; bioassay, n = 1) and consistently exceeded the upper 15% margin for 7 laboratories (LC-MS/MS and LC-UV, n = 3 each; LC-FL, n = 1).
Conclusions:
Alignment of methodologies among laboratories may be warranted to improve the accuracy and reproducibility of therapeutic drug measurements.
Insights
This study evaluated isavuconazole plasma concentration assays across 27 labs. Results show significant variability, indicating a need for standardized methods to ensure accurate therapeutic drug monitoring for fungal infections.
Area of Science:
- Clinical Chemistry
- Pharmacology
- Mycology
Background:
- Clinicians may monitor isavuconazole levels for invasive aspergillosis and mucormycosis.
- The accuracy and reproducibility of laboratory assays for isavuconazole plasma concentrations are not well-established.
Purpose of the Study:
- To assess the accuracy and reproducibility of isavuconazole plasma concentration quantification across multiple European laboratories.
- To compare different assay methods, including LC-MS/MS, LC-UV, LC-FL, and bioassay.
Main Methods:
- A round-robin study involving 27 European laboratories was conducted.
- Human plasma samples with known isavuconazole concentrations were analyzed in two independent rounds.
- Assay methods used were liquid chromatography-tandem mass spectrometry (LC-MS/MS), LC with ultraviolet detection (LC-UV), LC with fluorescence detection (LC-FL), and bioassay.
Main Results:
- Determined concentrations generally aligned with nominal values, but with significant inter-laboratory and inter-assay variability.
- Ten laboratories consistently reported concentrations within 15% of nominal values.
- Seven laboratories consistently exceeded the upper 15% margin, highlighting potential accuracy issues.
Conclusions:
- There is a need to align methodologies among laboratories to improve the accuracy and reproducibility of isavuconazole therapeutic drug measurements.
- Standardization is crucial for reliable therapeutic drug monitoring in patients treated with isavuconazole.
More Related Videos
Related Concept Videos
Therapeutic Drug Monitoring: Drug Analysis Methods
Measurement of Bioavailability: Pharmacokinetic Methods
Measurement of Bioavailability: Pharmacodynamic Methods
Bioequivalence studies: Biowaivers
In Vitro Drug Dissolution: Compendial Testing Models II
In Vitro Drug Dissolution: Compendial Testing Models I


